RecruitingNCT04845893
Observational Study on Skeletal Ewing's Sarcoma
Observational Study on Treatment of Skeletal Ewing Sarcoma at Diagnosis
Sponsor
Italian Sarcoma Group
Enrollment
100 participants
Start Date
Jun 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by skeletal Ewing Sarcoma
Eligibility
Min Age: 0 YearsMax Age: 49 Years
Inclusion Criteria6
- Diagnosis of Ewing's sarcoma of the bone
- Diagnosis of Ewing-like sarcoma (round cell sarcoma with fusion of the EWSR1 gene with others not of the ETS family, sarcoma with CIC rearrangement or sarcoma with BCOR rearrangement)
- Diagnosis of extraosseous Ewing's sarcoma for patients
- Age at diagnosis \<50 years
- Assessment of the extent of the disease at onset in accordance with the European Society of Medical Oncology guidelines
- Patients or parents oe guardians of minors who have given their written informed consent to participate in the study
Exclusion Criteria1
- \. Presence of comorbid factors who can compromise the compliance of the treatment plan or the evaluation of the outcomes, including but not limited to organ pathologies that contraindicate the use of chemotherapy and psychological or social conditions that do not allow for adequate compliance treatment or adequate follow-up
Interventions
OTHERTreatment of Ewings Sarcoma of bone according clinical practice (includes drugs, surgery, radiotherapy or any other received treatments)
This observational study collects all the treatments received by the patients according clinical practices or experimental trials and therefore includes drug/biological/surgical/ radiotherapy and any other applicable treatments
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04845893